Histogenics regeneration

Sofinnova leads recap deal for regenerative medicine play Histogenics

Histogenics regeneration

Sofinnova Ventures made its first regenerative medicine investment last month when it led a $49 million round that recapped Histogenics Corp.

New investors Split Rock Partners; BioMed Ventures; and FinTech GIMV Fund participated along with

Read the full 353 word article

How to gain access

Continue reading with a
two-week free trial.